Two Sigma Investments’s Jazz Pharmaceuticals JAZZ Stock Holding History

Two Sigma Investments’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,200	Closed	-$917K	–	3471
2021 Q4	$917K	Sell	7,200 -22,700	-76%	-$2.98M	﹤0.01%	2638
2021 Q3	$3.89M	Buy	+29,900	New	+$4.52M	0.01%	1424
2020 Q1	–	Sell	-1,900	Closed	-$284K	–	3471
2019 Q4	$284K	Sell	1,900 -1,100	-37%	-$150K	﹤0.01%	3219
2019 Q3	$384K	Buy	+3,000	New	+$402K	﹤0.01%	2763
2017 Q4	–	Sell	-7,200	Closed	-$1.05M	–	3263
2017 Q3	$1.05M	Buy	+7,200	New	+$1.09M	﹤0.01%	1697
2017 Q1	–	Sell	-4,200	Closed	-$458K	–	3100
2016 Q4	$458K	Buy	+4,200	New	+$468K	﹤0.01%	2559
2016 Q1	–	Sell	-3,000	Closed	-$422K	–	2957
2015 Q4	$422K	Buy	+3,000	New	+$416K	﹤0.01%	2064

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Two Sigma Investments's JAZZ Position: Q1 2026 in Review

Two Sigma Investments increased its Jazz Pharmaceuticals (JAZZ) stake by 717% in Q1 2026, buying an estimated $3.01M and bringing the position to 19,600 shares worth $3.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

Two Sigma Investments first reported a position in JAZZ in Q2 2013 and has held it in 40 quarters since. The position peaked at $65.2M in Q2 2016. 571 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Two Sigma Investments held 19,600 shares of Jazz Pharmaceuticals worth $3.71M as of Q1 2026.
Two Sigma Investments bought 17,200 Jazz Pharmaceuticals shares in Q1 2026, an estimated $3.01M.
Jazz Pharmaceuticals made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #2243 holding.
Two Sigma Investments first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 40 quarters since.
Two Sigma Investments's Jazz Pharmaceuticals position peaked at $65.2M in Q2 2016.
571 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.